23andMe lowers price to $99
Money and Finance

23andMe lowers price to $99


This price cut is a key part of our drive to grow the 23andMe member base to one million people. This will power research and medical breakthroughs and allow all of us together to revolutionize health care and help people live longer, healthier lives.

.................

Related article: 23andMe wants to change the face of health care





- Seize The Aca: The Innovator’s Guide To The Affordable Care Act – By Ben Wanamaker And Devin Bean
Throughout history, disruptive innovations have repeatedly, and often predictably, transformed entire industries through the introduction of affordable and accessible products and services. Personal computers, automobiles, mobile phones, airplanes, and...

- Eric Topol On Econtalk
Eric Topol of the Scripps Research Institute and the author of The Creative Destruction of Medicine talks with EconTalk host Russ Roberts about the ideas in his book. Topics discussed include "evidence-based" medicine, the influence of the pharmaceutical...

- Interview With Atul Gawande - By Alex Howard
Found via Simoleon Sense. Dr. Atul Gawande (@Atul_Gawande) has been a bard in the health care world, straddling medicine, academia and the humanities as a practicing surgeon, medical school professor, best-selling author and staff writer at the New Yorker...

- Delivering Dividends With Owens & Minor Inc.
I currently own just 3 companies that are directly health care related, although I do own some health care REITs that provide additional exposure to the industry. According to a 2014 report from the Census Bureau, the 65+ population in the United States...

- Walgreen's Stock Analysis
I've been meaning to post some more stock analysis' so today we'll look at one of my recent buy's, Walgreen's.  On Friday, November 2nd, Walgreen's closed at $34.88. Company Background: Walgreen Co., together with its subsidiaries,...



Money and Finance








.